Login to Your Account



All About The B-Cells

Weighing Various Lupus Bids: Rituxan A Winner Here, Too?

By Randall Osborne


Monday, June 18, 2007
Finding a drug that can re-educate the body's confusion in lupus has proven a puzzler for biotech firms for years, and opinion is divided on which companies might be getting close to a fix for the devilish disease. Is there a way to teach the immune system the difference it once knew between foreign antigens and its own? (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription